Answers are grounded in this paper and cite their sources.
A new delivery system (Preci-Jet 50) which administers growth hormone through the skin using high pressure and without a needle was evaluated. This device was inconvenient and painful compared with a pen injection system. The conclusion is that the Preci-Jet is not the panacea for solving the problem of compliance with subcutaneous growth hormone injections.
No takes yet. Share an insight, caveat, or question.
Bareille et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: